SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The thread of life -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (125)3/31/2001 5:32:33 AM
From: Mike McFarlandRespond to of 1336
 
I happened to see the Frontline on Xenotransplantation too,
but I wont run over to the btrn thread to respond. I will
say that it does not seem fair that a person might
overindulge on pork chops and bacon, then expect a pig
heart when he has worn out his original! Sure, the young
fella, heart apparently ravaged by a pathogen, should
probably get a heart. The part about the young woman
recovering from the stroke was interesting...recombination
threat and all that...

Guess I'll have to hit google and do some reading.
nature.com

This is interesting!
nature.com



To: Mike McFarland who wrote (125)4/1/2001 2:31:40 PM
From: Extra PaleRead Replies (1) | Respond to of 1336
 
Regarding gene therapy stocks, seems to me they may be hitting a bottom (simply gut feel no facts or attempt to verify). When was the last time there was any positive press? or any press for that matter? Am buying back cege for my portfolio because of cash/mkt cap ratio; emphasis on gene therapy, gvax phase 3 and of course abgx back door. Putting it in retirement account -- hope social security is still around in 25 years... -g-


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News